Global elimination of trachoma: How frequently should we administer mass chemotherapy?
- 1 May 1999
- journal article
- research article
- Published by Springer Nature in Nature Medicine
- Vol. 5 (5) , 572-576
- https://doi.org/10.1038/8451
Abstract
The World Health Organization has recommended repeat mass drug administration as part of their global initiative to eliminate blinding trachoma by the year 2020. The efficacy of repeat treatment will be tested empirically, but the results will not be available for many years, and recommendations for the necessary frequency of treatment are needed immediately. We have developed a mathematical model that uses available epidemiological data from a variety of countries. We recommend, based on our analysis, that in areas where trachoma is moderately prevalent (50% in children), it should be treated biannually.Keywords
This publication has 33 references indexed in Scilit:
- Control Strategies for Tuberculosis Epidemics: New Models for Old ProblemsScience, 1996
- Modeling heterogeneous mixing in infectious disease dynamicsPublished by Cambridge University Press (CUP) ,1996
- Molecular epidemiology of trachoma in a Gambian village.British Journal of Ophthalmology, 1994
- Single Dose Azithromycin Treatment of Gonorrhea and Infections Caused by C. trachomatis and U. urealyticum in MenSexually Transmitted Diseases, 1994
- Randomised controlled trial of single-dose azithromycin in treatment of trachomaPublished by Elsevier ,1993
- Drugs, sex and HIV : a mathematical model for New York CityPhilosophical Transactions Of The Royal Society B-Biological Sciences, 1991
- Networks of sexual contactsAIDS, 1989
- Trachoma and blindness in the Nile Delta: current patterns and projections for the future in the rural Egyptian population.British Journal of Ophthalmology, 1989
- Fifteen-Month Follow-up Study of Women Infected withChlamydia trachomatisNew England Journal of Medicine, 1979
- Severe endemic trachoma in Tunisia.British Journal of Ophthalmology, 1976